In the News

Video and Photos: APTA 2024 Combined Sections Meeting

Networking, learning, celebrating, and more: Reminisce or see what you missed — and get on-demand access to 100+ sessions starting March 15.

The APTA Combined Sections Meeting 2024 has come and gone, but if you were there, chances are you won't be forgetting the event any time soon.

More than 16,000 members of our community came together in Boston for learning and networking. This year's event featured more than 1,200 research posters, 400 sessions from APTA’s 18 specialty sections, 450 exhibitors, the 55th Mary McMillan Lecture, and a specialist recognition ceremony. There were also countless opportunities to connect, including the PT Fund Celebration of Diversity and PTPAC's annual party.

If you missed it, more than 100 sessions, along with digital posters, will be available for on-demand viewing from March 15 to April 15.

Read Full Article

 

Join APTA for a Trip to Capitol Hill (and More), April 14-16

APTA

The physical therapy profession's advocacy voice continues to grow stronger. And now's your chance to join in.

Coming April 14-16: APTA Capitol Hill Day, a one-of-a-kind event that brings together PTs, PTAs, and students from across the country for a day of focused, in-person engagement with legislators and their staff. It's an opportunity to make direct connections with policymakers to educate them on the value of physical therapy and the changes needed to improve patient access to needed care. But it's more than a one-day experience.

The visit to Capitol Hill, on April 16, comes after a day of education around some of the major issues facing the profession, as well as training on how to make your meetings with legislators as effective as possible. The program includes special speakers, breakout sessions (including one specifically for students), and state delegation meetings — all capped off by a party to celebrate PTPAC, the profession's political action committee. Cost is $250 for APTA members, $100 for students, and free for Federal Affairs Liaisons, PTPAC Eagle Club members, and APTA component executive directors.

Registered attendees will also be able to participate in an exclusive pre-event webinar on April 10 at 8 p.m. ET that will provide information on logistics and target advocacy issues, with a recording available for registrants who can't make the live event.

Check out the tentative agenda, watch a video, and register now at the APTA Capitol Hill Day webpage.
 

Health Care Quality Took a Big Hit During COVID, Medicare Report Finds

Axios | By Maya Goldman
 
Progress on many key health care quality measures was reversed during the first two years of the pandemic, according to a new comprehensive federal review. 
 
Why it matters: The report identified a "significant worsening" of patient safety measures and "persistent" health equity gaps for historically disadvantaged patients as COVID-19 overwhelmed the health care system. 
 
Context: The federal government asks providers to report on a wide set of several hundred measures meant to assess health care quality. 

  • Before the pandemic, from 2016 to 2019, providers' performance on more than half of quality metrics improved, the Centers for Medicare and Medicaid Services said. 
  • CMS relaxed reporting requirements when the pandemic hit, but the agency said it continued to collect enough data to compare performance with long-term trends. 


Zoom in: Performance on 38% of measures came in worse than expected in 2020, and 47% worse in 2021, CMS said. 

  • About half of safety measures came in worse than expected in those two years. 
  • In the starkest example, a measure of central line-associated bloodstream infections was 94% worse than expected in 2021.

 
Quality scores decreased more significantly for minority populations on some measures. 

  • For instance, osteoporosis management for Black Medicare Advantage enrollees was 22.4 percentage points worse in 2021, while it fell 14.4 percentage points for white enrollees. 

 
The bottom line: CMS said the data and feedback from focus groups show the need to develop measures that "address bias in care delivery and deficits in cultural competency, unmet health-related social needs, access, and health literacy."

 

Is Stretching Now Underrated? Accumulating Research Says Yes

Medscape | By Lou Schuler

For many, stretching is the fitness equivalent of awkward small talk. It's the opening act, the thing you tolerate because you know it will be over soon. 

Others have challenged the practice, suggesting that stretching isn't necessary at all. Some research has found that a preworkout stretch may even be disadvantageous, weakening muscles and hindering performance.

To put it plainly, no one seems terribly enthusiastic about touching their toes. 

That's why a 2020 study on exercise and mortality was such a head-scratcher. The study found that stretching was uniquely associated with a lower risk for all-cause mortality among American adults. That's after controlling for participation in other types of exercise. 

The finding seemed like a fluke, until a 2023 study found essentially the same thing. 

Among Korean adults, those who did flexibility exercise at least five times a week had a 20% lower risk of dying during the follow-up period than those who didn't stretch at all. That was slightly better than the risk reduction associated with high volumes of aerobic exercise and resistance training. 

How can that be ? It turns out, stretching is linked to several health benefits that you might not expect. 

The Surprising Benefits of Stretching

When we talk about stretching, we usually mean static stretching — getting into and holding a position that challenges a muscle, with the goal of improving range of motion around a joint. 

It doesn't need to be a big challenge. "Research shows you can get increases in flexibility by stretching to the initial point of discomfort," said David Behm, PhD, an exercise scientist at Memorial University of Newfoundland in Canada who's published dozens of studies on stretching over the past quarter-century. 

That brings us to the first benefit…

Read Full Article

 

Promising New Wearable Could Retrain the Brain After Stroke

Medscape | By Sarah Amandolare

A new and deceptively simple advance in chronic stroke treatment could be a vibrating glove.

Researchers at Stanford University and Georgia Tech have developed a wearable device that straps around the wrist and hand, delivering subtle vibrations (akin to a vibrating cellphone) that may relieve spasticity as well as or better than the standard Botox injections.

"The vibro-tactile stimulation can be used at home, and we're hoping it can be relatively low cost," said senior study author Allison Okamura, PhD, a mechanical engineer at Stanford University, Stanford, California.

For now, the device is available only to clinical trial patients. But the researchers hope to get the glove into — or rather onto — more patients' hands within a few years. A recent grant from the National Science Foundation's Convergence Accelerator program could help pave the way to a commercial product. The team also hopes to expand access in the meantime through larger clinical trials with patients in additional locations.

The work builds on accumulating research exploring vibration and other stimulation therapies as treatments for neurological conditions. Other vibrating gloves have helped reduce involuntary movement for patients with Parkinson's. And the University of Kansas Medical Center, Kansas City, Kansas, will soon trial the Food and Drug Administration-approved vagal nerve stimulator, an implantable device intended to treat motor function in stroke survivors. Okamura noted that devices use "different types of vibration patterns and intensities," depending on the disease state they target.

Spasticity often develops or worsens months after a stroke. By then, patients may have run out of insurance coverage for rehabilitation. And the effectiveness of Botox injections can "wear out over time," Okamura said.

In a clinical trial, patients wore the device for 3 hours a day for 8 weeks, while doing their usual activities. The researchers continued testing their spasticity for 2 more weeks. Symptom relief continued or improved for some patients, even after they stopped using the device. More than half of the participants experienced equal or better results than another group that only received regular Botox injections.

Read Full Article

 
<< first < Prev 1 2 3 4 5 6 7 8 9 10 Next > last >>

Page 9 of 111